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Background. In rural areas, many patients with malaria seek care at peripheral health facilities or community case management 
programs. While this strategy is effective for the management of uncomplicated malaria, severe malaria necessitates prompt detec-
tion and referral to facilities with adequate resources.
Methods. In this prospective, observational cohort study, we assessed the accuracy of a dual-band (histidine-rich pro-
tein-2/pan-lactate dehydrogenase [HRP2/pLDH]) rapid diagnostic test (RDT) to differentiate uncomplicated from severe malaria. 
We included children aged <12 years who presented to a rural clinic in western Uganda with a positive HRP2 or HRP2/pLDH 
RDT. We estimated the test characteristics of a dual-antigen (HRP2+/pLDH+) band positive RDT compared to World Health 
Organization–defined clinical and laboratory criteria to detect severe malaria.
Results. A total of 2678 children underwent testing for malaria with an RDT, and 83 (9.0%) satisfied criteria for severe malaria. 
The sensitivity and specificity of a HRP2+/pLDH+ result for severe malaria was 97.6% (95% confidence interval [CI], 90.8%–99.6%) 
and 75.6% (95% CI, 73.8%–77.4%), respectively. An HRP2+/pLDH+ result was significantly more sensitive (97.6% vs 68.7%, P < 
.001) for the detection of severe malaria compared to algorithms that incorporate screening for danger signs.
Conclusions. A positive dual-antigen (HRP2/pLDH) RDT has higher sensitivity than the use of clinical manifestations to detect 
severe malaria, making it a promising tool in the triage of children with malaria in low-resource settings. Additional work is needed 
to operationalize diagnostic and treatment algorithms that include dual-antigen RDTs to avoid over referral.
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Each year millions of children are infected with Plasmodium 
falciparum malaria, and approximately 300 000 die from mani-
festations of severe disease [1]. In Uganda, like much of sub-Sa-
haran Africa, malaria is a leading cause of child mortality and 
has historically accounted for nearly half of inpatient pediatric 
deaths [2, 3]. Many who suffer from severe malaria, however, do 
not reach a health facility, and thus a large proportion of deaths 
take place outside the formal healthcare sector [4–6].
Patients may initially seek care at peripheral health facilities 
that are staffed by health workers with only basic training in 
malaria case management. In Uganda, these level II and level 
III facilities may lack the requisite infrastructure to perform 
microscopy or other tests that may yield evidence of severe 
malaria (Table 1) [7, 8]. Malaria-endemic countries have also 
increasingly adopted community case management strategies, 
which provide for malaria diagnosis and treatment by lay mem-
bers of the community outside of health facilities [9, 10].
While these programs improve access to care [11], community 
health workers and peripheral health centers are not equipped 
with the laboratory infrastructure (eg, lactate and bicarbonate 
testing) required to diagnose severe malaria. Instead, providers 
are instructed to refer suspected cases to a higher level of care 
[12, 13]. The decision to refer, however, depends on the per-
formance of a detailed physical exam and the identification of 
abnormal clinical signs, which may not be recognized by ancil-
lary staff and lay health workers [14, 15].
One advance in rapid diagnostic test (RDT) technology is 
the development of assays that combine different antigens on 
a single membrane. Some reports suggest that the pattern of 
antigen band positivity can provide a semiquantitative estimate 
of P. falciparum parasite density [16–18], with dual-antigen 
band-positive tests signifying higher parasite densities. Given 
the association between higher levels of parasitemia and severe 
malaria [19], we hypothesized that dual-band positive tests may 
help discriminate between uncomplicated and severe malaria 
among children in rural Uganda.
Our objective in this prospective, observational study was 
to evaluate the validity of a dual-antigen RDT as a screening 
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tool for severe malaria and compare its performance to stand-
ard, clinical-based diagnostic criteria. Our overarching goal was 
to identify a low-cost, easy-to-interpret method for detecting 
severe malaria and guide referral decisions in community-based 
fever management programs and at peripheral health centers in 
resource-limited settings where microscopy and advanced lab-
oratory capacity are not routinely available.
METHODS
Study Setting
The Bugoye Level III Health Center in the Kasese District of 
western Uganda serves a rural population of approximately 
50 000 residents. Clinical officers, nurses, midwives, and labora-
tory technicians employed by the Ugandan Ministry of Health 
staff the health center. The climate in Bugoye permits year-
round malaria transmission marked by semiannual transmis-
sion peaks typically following the end of the rainy seasons [20].
Study Design
The RDTs for Severe Malaria study was a prospective, observa-
tional cohort study of patients with a parasitological diagnosis 
of malaria conducted from May 2015 to November 2015. Study 
staff recorded demographic information, clinical history, and 
vital signs on all individuals who presented to the outpatient 
department. Health facility staff, typically nurses and clinical 
officers, performed clinical evaluations of all patients in accord-
ance with local protocols. Individuals with fever (axillary tem-
perature ≥38oC) or other symptoms suspicious for malaria as 
determined by the attendant provider were eligible for inclu-
sion. Individuals aged >12 years and those who presented with-
out a caregiver were excluded.
The health center laboratory staff performed initial testing 
for malaria using the Standard Diagnostics 05FK60 Malaria Ag 
P.f/Pan RDT assay (Hagal-Dong, Korea). The RDT, which has
been prequalified by the World Health Organization (WHO), is
an antigen detection test with 3 bands signifying the control, the 
histidine-rich protein-2 (HRP2), and the pan-lactate dehydro-
genase (pLDH) antigens [21, 22]. The presence of a single HRP2 
line (herein referred to as a HRP2+/LDH– result) denotes infec-
tion with P. falciparum, whereas a unique pLDH line (herein
referred to as HRP2–/pLDH+) indicates infection with 1 or
more of the other Plasmodium species. The presence of a pos-
itive HRP2 line together with a pLDH line (HRP2+/pLDH+) 
indicates an infection with P. falciparum or a mixed-species 
infection. RDTs for the study were obtained directly from the 
manufacturer, stored in the original packaging at room temper-
ature, and used prior to the expiration date. We included partic-
ipants with at least 1 single-band positive RDT in this analysis.
Study staff with training in laboratory medicine prepared 
thin and thick blood smears for all children with a positive RDT 
result. Children with a negative RDT were defined as not having 
severe malaria and did not undergo further testing, except for the 
15% of individuals who underwent microscopy for the purpose 
of quality control. Smears were fixed with methanol and stained 
in 10% Giemsa. Microscopists who had undergone validation 
testing (Shoklo Malaria Research Unit) and were blinded to the 
RDT results reviewed all slides in accordance with WHO/Tropical 
Disease Research guidelines [23]. Two independent microscopists 
read all slides. A third, senior microscopist reviewed slides when 
there were discrepancies between the first 2 reads in the presence 
of parasitemia, species identification, or differences (>10%) in 
parasite density. Dried blood spots were obtained from a subset 
of participants over a 1-month period, and real-time polymerase 
chain reaction (PCR) was performed to assess the accuracy of 
microscopy [24].
Hemoglobin levels were measured using the Hemocue Hb 
201+ analyzer (Brea, California), while serum chemistry and 
venous blood gas values were obtained using the Abbott iStat 
analyzer (Princeton, New Jersey) with the CHEM8+ and CG4+ 
cartridges. Estimates of hemoglobinuria were made using a 
UroColor 11 dipstick urinalysis assay (Standard Diagnostics, 
Hagal-Dong, Korea). All point-of-care tests were calibrated 
daily by study staff and performed in accordance with the man-
ufacturers’ instructions.
Patients with any positive RDT result were treated by health 
center staff in accordance with local standards of care. We 
recorded treatment and disposition plans, including admission 
to the inpatient ward and referral to higher-level facilities.
Statistical Analyses
Data were double-entered into Microsoft Excel (Redmond, 
Washington) and analyzed with Stata 12.1 (College Station, 
Table 1. Study Criteria for Severe Malaria Required Plasmodium falciparum Parasitemia on Microscopy and Any One of the Following
Impaired consciousness Blantyre coma score <3 for children aged <5 years or Glasgow coma score <11 for children aged >5 years 
Metabolic acidosis Plasma bicarbonate of <15 mmol/L or venous plasma lactate >5 mmol/L
Hypoglycemia Blood or plasma glucose <40 mg/dL (<2.2 mmol/L)
Severe anemia A hemoglobin concentration <5 g/dL in children aged <12 years and <7 g/dL in adults together with a parasite count >10 000/uL
Kidney injury Plasma or serum creatinine >3 mg/dL and blood urea nitrogen ≥20 mg/dL
Pulmonary edema Oxygen saturation <92% on room air with a respiratory rate >30/min
Abnormal bleeding Hemoglobinuria of ≥4+ on dipstick urinalysis (250 red blood cells)
Shock Systolic blood pressure <70 mm Hg
Convulsions History of seizures during present illness
Hyperparasitemia Plasmodium falciparum parasitaemia >250 000/μL
Texas). We summarized patient characteristics and compared 
them between those with HRP2+/pLDH– and HRP2+/pLDH+ 
results using Student t test for continuous variables and Pearson 
χ2 test for categorical variables. Parasite densities were log-trans-
formed and reported as geometric means.
For our primary analysis, we assessed the validity of the 
dual-antigen RDT to detect severe malaria in children aged <12 
years. To do so, we defined severe malaria in accordance with 
the guidelines for research and epidemiological studies [4]. We 
used the threshold of 250 000 parasites/μL (approximately 5%) 
to define hyperparasitemia. We defined abnormal bleeding as 
the presence of gross hemoglobinuria (4+ on urinalysis). These 
criteria are outlined in Table 1.
We estimated the sensitivity, specificity, and negative and 
positive likelihood ratios for a HRP2+/pLDH+ result (vs a 
HRP2+/pLDH– result) to identify severe malaria. Using our 
estimated sensitivity and specificity results and a range of severe 
malaria prevalence from 1% to 30%, we then assessed the nega-
tive (NPV) and positive predictive values (PPV) of the tests. We 
repeated these analyses restricted to children aged <5 years. We 
performed sensitivity analyses of these estimates by liberalizing 
thresholds for a number of criteria that define severe malaria.
Finally, we evaluated the test characteristics of the RDT 
for the detection of severe malaria in comparison to clinician 
impressions, which comprise key physical exam findings often 
termed “danger signs” (eg, impaired consciousness, shock, aci-
dotic breathing) in the setting of P. falciparum parasitemia, as 
used by the health center clinical staff under routine conditions 
[4]. We recorded disposition plans (eg, discharge, admit, refer) 
as a surrogate marker for the presence of such danger signs. We 
also evaluated the test characteristics of the RDT compared to 
a “bedside exam,” which we defined as the presence of outward 
clinical manifestations of severe malaria according to the cri-
teria listed in Table 1 (eg, impaired consciousness, pulmonary 
edema, seizures) prior to a confirmed parasitological diagnosis 
or other laboratory-based evidence of severe malaria.
Ethics Statement
The institutional review boards of Partners Healthcare, the 
University of North Carolina at Chapel Hill, the Mbarara 
University of Science and Technology, and the Uganda National 
Council for Science and Technology provided ethical approval 
of the study. Written informed consent was obtained from all 
study participants.
RESULTS
Diagnostic Testing and Clinical Manifestations
A total of 2701 children aged <12 years presented with a clin-
ical history and/or symptoms concerning for malaria. Baseline 
characteristics of the study cohort are shown in Table 2.
RDT results were available on 99.2% (2678/2701) of 
patients, nearly half (1248/2678, 46.6%) of whom displayed at 
least 1 positive antigen band. The HRP2+/pLDH+ result was 
the most common, accounting for 67.8% of all positive results, 
while an isolated HRP2 band (HRP2+/pLDH–) was seen in 
30.7%, and a single pLDH band (HRP2–/pLDH+) in less than 
2% of positive results. Of those participants with any positive 
RDT result, 75% (936/1248) chose to pursue additional diag-
nostic testing in the study protocol and were subsequently 
included in the analysis.
Table 2. Baseline Demographic and Clinical Characteristics Stratified by Rapid Diagnostic Test Result 
Baseline Characteristic All HRP2+/pLDH– HRP2+/pLDH+ P Value
Patients (n, %) 2678 383 (14.3) 846 (31.6) —
Age, y (median, IQR) 5 (2–8) 6 (3 - 9) 6 (3–9) .79
 5–12 1438 (53.2) 246 (64.2) 545 (64.4) .95
 <5 1263 (46.8) 137 (35.8) 301 (35.6)
Male sex (n, %) 1331 (50.2) 190 (50.0) 438 (52.4) .44
Days since symptom onset (median, IQR) 2 (2–3) 3 (2 - 3) 2 (2 - 3) .001
Reported symptoms (n,%)
 Fever 2192 (81.2) 351 (91.6 794 (93.9) .16
 Cough 1443 (53.4) 214 (55.9) 381 (45.0) <.001
 Rhinorrhea 719 (26.6) 105 (27.4) 185 (21.9) .03
 Arthralgias/Myalgias 316 (11.7) 52 (13.6) 135 (16.0) .28
 Diarrhea 408 (15.1) 43 (11.2) 114 (13.5) .27
Convulsion 43 (1.6) 5 (1.3) 20 (2.4) .22
Vital signs (n, %)
 Febrile 474 (18.2) 57 (15.5) 262 (31.9) <.001
 Tachycardic 464 (18.3) 64 (17.4) 543 (31.0) <.001
Hypotensive/Shock 79 (3.3) 8 (2.2) 24 (3.0) .45
Pulmonary edema 60 (2.6) 7 (1.9) 21 (2.7) .45
Text in bold represents measures that define criteria for severe malaria. 
Abbreviations: HRP2/pLDH, histidine-rich protein-2/pan-lactate dehydrogenase; IQR, interquartile range.
Nonparticipants were younger (median age 4 vs 7  years, 
P < .001) and more likely to have a HRP2+/pLDH– RDT result 
(31.1% vs 12.3%, P  <  .001) than participants included in the 
study. There were similar rates of fever (31.3% vs 29.4%, P = .56), 
tachycardia (26.3% vs 30.9%, P = .15), hypoxia (12.6% vs 8.7%, 
P = .06), hypotension (2.9% vs 2.6%, P = .8), and reported sei-
zures (3.2% vs 1.7%, P = .13) between those included and those 
not included. Rates of admission (29.9% vs 25.3%, P = .21) and 
referral (1.1% vs 0.3%, P = .19) were also similar.
Using microscopy as the reference standard, the overall sen-
sitivity of the RDT for the diagnosis of P. falciparum malaria was 
98.2% (95% confidence interval [CI], 96.8%–99.0%). The spec-
ificity was 89.1% (95% CI, 85.9%–91.7%) for HRP2+/pLDH+ 
results and 52.1% (95% CI, 47.3%–57.0%) for HRP2+/pLDH– 
results (P < .001). Among the subset of samples that underwent 
parallel real-time PCR (n = 112), slide reading demonstrated a 
high degree of agreement (κ  =  0.94). Plasmodium falciparum 
accounted for 95.4% of infections, while Plasmodium malar-
iae, Plasmodium ovale, and mixed P. falciparum accounted for 
2.3%, 1.2%, and 1.2% of infections, respectively, as determined 
by microscopy.
Results of blood and urine testing to assess for severe malaria 
are shown in Table 3. Those with HRP2+/pLDH+ results had 
significantly higher levels of parasitemia compared to indi-
viduals with HRP2+/pLDH– results (geometric mean, 13 051 
parasites/μL vs 1126 parasites/μL, P  <  .001). All cases above 
the clinically relevant threshold of 100 000 parasites/μL and 
all 17 cases of hyperparasitemia were observed in the HRP2+/
pLDH+ group.
Severe Malaria
A total of 83 (9.0%) children with a positive HRP2 or HRP2/
pLDH RDT satisfied criteria for severe malaria. The sensi-
tivity and specificity of a HRP2+/pLDH+ result for severe 
malaria was 97.6% (95% CI, 90.8%–99.6%) and 75.6% (95% 
CI, 73.8%–77.4%), respectively (Table 4). Two children with 
single-antigen HRP2+/pLDH– results met criteria for severe 
malaria. One had pulmonary edema, tachycardia, elevated 
lactate (2.5  mmol/L), and a parasite density of 10 087/μL, 
while another had shock (systolic blood pressure 61  mm 
Hg), elevated lactate (2.3 mmol/L), and a parasite density of 
21 208/μL.
Using a severe malaria prevalence of 3.5% (83/2349) among 
all children who presented for testing, a HRP2+/pLDH+ result 
demonstrated a near-perfect NPV for the diagnosis of severe 
malaria (99.9%, 95% CI, 99.5%–99.9%) and a PPV of 12.8% 
(95% CI, 10.4%–15.7%). These estimates were robust to ranges 
of severe malaria prevalence from as low as 1% to as high as 30% 
(Supplementary Table 1).
When we restricted the analysis to children aged <5  years 
(Table  4), the proportion of children with severe malaria 
increased to 14.0% among those with a positive RDT. All 37 
cases of severe malaria were identified by a HRP2+/pLDH+ 
RDT, with a resulting sensitivity of 100% (95% CI, 86.6%–
100.0%), PPV of 20.9% (95% CI, 15.3%–27.8%), and NPV of 
100% (95% CI, 99.5%–100.0%).
In multiple sensitivity analyses, we found that changes in the 
diagnostic criteria for severe malaria resulted in the identifi-
cation of more cases but did not significantly impact the high 
Table 3. Laboratory Results for Patients With Confirmed Plasmodium falciparum Parasitemia Stratified by Rapid Diagnostic Test Result 
Characteristic HRP2+/pLDH– HRP2+/pLDH+ P Value
Patients (n, %) 77 579 —
Microscopy results
Parasitemia (geometric mean, 95% CI) 1126/μL (686–1849) 13 051/μL (11 201–15 208) <.001
Density >10 000 (n,%) 13 (16.3) 340 (59.4) <.001
Density >100 000 (n,%) 0 (0.0) 81 (14.1) <.001
Hyperparasitemia 0 (0.0) 17 (3.0) .12
Gametocytes (n, %) 5 (5.8) 33 (5.7) .99
Anemia
Hemoglobin (mean, 95% CI) 11.5 g/dL (11.3–11.7) 11.0 g/dL (10.8–11.1) <.001
Hb <5 g/dL (n,%) 0 (0.0) 2 (0.4) 1.00a
Hb <7 g/dL (n,%) 0 (0.0) 21 (3.8) .09
Hypoglycemia (n,%) 0 (0.0) 2 (0.4) 1.00a
Kidney injury (n, %) 0 (0.0) 0 (0.0) -
Metabolic acidosis (n,%)
Lactate (mean, 95% CI) 1.73 mmol/L (1.52–1.94) 2.18 mmol/L (2.08–2.27) .001
Lactate >5 mmol/L 0 (0.0) 13 (2.6) .19
 HCO3 (mean, 95% CI) 23.2 mmol/L (22.6–23.9) 22.6 mmol/L (22.2–22.9) .20
HCO3 < 15 (n,%) 0 (0) 8 (1.6) .61a
Hematuria (n,%) 0 (0) 11 (2.1) .22
Text in bold represents measures that define criteria for severe malaria.
Abbreviations: CI, confidence interval; HCO3, bicarbonate; HRP2/pLDH, histidine-rich protein-2/pan-lactate dehydrogenase.  
aTwo sided P value obtained using Fisher exact test. 
sensitivity and NPV of the RDT, as all additional cases were 
identified in the HRP2+/pLDH+ positive group (Supplementary 
Table 2).
The use of clinical findings to identify severe malaria among 
those with a positive RDT result had relatively poor diagnostic 
validity compared to a HRP2+/pLDH+ test. The combination of 
a positive HRP2 RDT and the clinical criteria for severe malaria 
had significantly lower sensitivity (57/83, 68.7% vs 81/83, 97.6%, 
P < .001) but higher specificity (90.5% vs 75.6%, P < .001) com-
pared to the multiple-antigen RDT. The most common manifes-
tations of severe malaria in cases missed by the clinical criteria 
were lactic acidosis (10, 38.5%), hyperparasitemia (7, 26.9%), 
and metabolic acidosis (6, 23.1%). The geometric mean level 
of parasitemia in the missed cases was not statistically different 
from those identified using the bedside criteria (P = .32).
Similarly, clinician impression and disposition decisions had 
poor diagnostic performance. Clinicians identified and made 
appropriate plans for admission or referral in only 40 of 76 cases 
of severe malaria. The sensitivity of clinical decision making 
was 52.6%, (P < .001 compared to HRP2+/pLDH+ RDT) and 
the specificity was 81.6% (P < .001).
Using HRP2+/pLDH+ results to trigger referrals for micros-
copy and parenteral antimalarials, however, would result in 
more than twice as many referrals as current protocols in wide-
spread use, which incorporate HRP2 RDTs and the bedside 
criteria, but would identify an additional 23 (27.7%) cases of 
severe malaria. Notably, when this analysis was restricted to 
children aged <5  years (Table  5), we found that the HRP2+/
pLDH+ RDT alone performed with significantly higher sensi-
tivity (100.0% vs 83.8%, P < .001) and similar specificity (86.6% 
vs 89.1%, P =  .08) compared to the combination of screening 
with a HRP2 RDT and clinical exam. Additionally, the increase 
in the number of referrals was small (n = 33, 3.1%, P = .05).
DISCUSSION
A positive dual-antigen (HRP2+/pLDH+) RDT result has high 
sensitivity (97.6%) and NPV (99.9%) for the detection of severe 
malaria among Ugandan children aged <12 years. The assay was 
more sensitive than current protocols that use clinical measures 
to distinguish uncomplicated malaria from severe malaria and 
does not require a detailed physical exam. These test character-
istics along with the low cost, wide distribution, and ease of use 
in the absence of laboratory infrastructure make it a promising 
screening tool to guide triage algorithms at peripheral health 
centers and to guide referral decisions in community-based 
fever management programs in resource-limited settings.
The relatively poor sensitivity of clinical symptoms and the 
clinical impression of health center staff to detect severe malaria 
was unexpected. More than half (16/26, 61.5%) of the cases 
missed by clinical scoring had severe lactic or metabolic acido-
sis, which has been associated with neurological involvement 
and increased mortality [25–29]. In contrast, the dual-band 
RDT result correctly identified all but 1 case of acidosis as well 
as all patients with hyperparasitemia.
When used to examine the study population of children aged 
<12 years, the assay was relatively nonspecific, and our results 
suggest that adoption of an algorithm based on dual-antigen 
RDTs would trigger significantly more referrals to health facili-
ties than existing protocols (Table 5). The relatively low specific-
ity of the assay might require alternate algorithms appropriate 
to local context in order to avoid overburdening fragile health-
care systems. Yet among children aged <5 years, in whom the 
Table 4. Test Performance of 2-Antigen Band Rapid Diagnostic Test for 
the Diagnosis of Severe Malaria Among Children 
Malaria diagnosis
Children Aged <12 Yearsa
RDT Nonsevere Severe Total
Negative and HRP2+/pLDH- 11 714 (99.9) 2 (0.1) 1716 (100.0)
HRP2+/pLDH+ 552 (87.2) 81 (12.8) 633 (100.0)
2266 (96.2) 83 (3.5) 2349 (100.0)
Children Aged <5 Yearsb
Negative and HRP2+/pLDH- 901 (100.0) 0 (0.0) 901 (100.0)
HRP2+/pLDH+ 140 (79.1) 37 (20.9) 177 (100.0)
1041 (96.6) 37 (3.4) 1078 (100.0)
Abbreviations: CI, confidence interval; HRP2/pLDH, histidine-rich protein-2/pan-lactate 
dehydrogenase; NPV, negative predictive value; PPV, positive predictive value; RDT, rapid 
diagnostic test; SENS, sensitivity; SPEC, specificity.
aSENS: 97.6% (95% CI, 90.8%–99.6%), SPEC: 75.6% (95% CI, 73.8%–77.4%), NPV: 
99.9% (95% CI, 99.5%–100.0%), and PPV: 12.8% (95% CI, 10.4%–15.7%).
bSENS: 100.0% (95% CI 86.6–100.0%), SPEC: 86.6% (95% CI 84.3–88.5%), NPV: 100.0% 
(95% CI 99.5–100.0%), and PPV: 20.9% (95% CI 15.3–27.8%).
Table 5. Test Characteristics of Various Algorithms for the Diagnosis of 












Children Aged <12 Years
Clinical impression 211 (23.3) 52.6 81.6 94.8 21.1
Bedside exam 997 (42.1) 68.7 58.9 98.1 5.7
HRP2 RDT+ and bedside 
exam
273 (11.6) 68.7 90.5 98.7 20.9
HRP2+/pLDH+ RDT 633 (27.0) 97.6 75.6 99.9 12.8
Children Aged <5 Years
Clinical impression 90 (36.4) 60.0 66.8 92.4 20.0
Bedside exam 722 (66.9) 83.8 33.8 98.3 4.3
HRP2 RDT+ and bedside 
exam
144 (13.4) 83.8 89.1 99.4 21.5
HRP2+/pLDH+ RDT 177 (16.4) 100.0 86.6 100.0 20.9
Clinical impression represents the disposition plan of the treating provider where a decision 
to admit or refer was considered evidence of “danger signs” and thus severe malaria. The 
bedside exam represents children who exhibited the outward clinical manifestations of severe 
malaria according to the criteria listed in Table  1 (eg, impaired consciousness, pulmonary 
edema, seizures) but did not have a confirmed parasitological diagnosis or other laborato-
ry-based evidence of severe malaria. The HRP2 RDT+ and bedside exam category represents 
children with a positive HRP2-only RDT who displayed danger signs and thus is consistent 
with current World Health Organization guidelines for the diagnosis of severe malaria.
Abbreviations: HRP2/pLDH, histidine-rich protein-2/pan-lactate dehydrogenase; NPV, neg-
ative predictive value; PPV, positive predictive value; RDT, rapid diagnostic test; Sens, sen-
sitivity; Spec, specificity.
prevalence of severe malaria was higher, this strategy demon-
strated high sensitivity (100.0%) and fair specificity (86.2%) 
for the detection of severe malaria. The PPV of 20.9% suggests 
that approximately 1 in 5 referred children would have severe 
malaria, which is similar to the number of referrals produced 
by current protocols. Further studies are needed to validate and 
operationalize diagnostic and treatment algorithms that incor-
porate the dual-antigen RDT.
The strengths of our study include the large sample size, com-
prehensive laboratory analysis, and comparison to “real-world” 
clinically based diagnoses. Our study also has a number of 
limitations. First, we used expert microscopy rather than PCR 
as the reference standard for RDT accuracy, which may have 
resulted in a small misclassification bias. However, quality con-
trol testing on a subset of our results comparing microscopy to 
PCR demonstrated excellent agreement (κ = 0.94) between the 
2 methods. Additionally, false-negative microscopy results were 
likely due to low levels of parasitemia, which is less commonly 
associated with severe malaria.
Second, our overarching goal was to identify a low-cost 
tool for detecting severe malaria and for guiding referral deci-
sions in community-based fever management programs and 
at peripheral health centers where microscopy and advanced 
laboratory capacity are not routinely available. However, our 
study was conducted at a level III health center with the ability 
to diagnose and manage severe malaria. Thus, the study popu-
lation may not be directly generalizable to more peripheral sites. 
However, to account for this, we assessed the NPV and PPV of 
the assay across a range of severe malaria prevalence estimates.
Additionally, we conducted the study in a setting of P.  fal-
ciparum predominance, where non–P.  falciparum infections 
account for an extremely low proportion (3.5%) of infections. 
Therefore, our fi ndings, wh ich re ly on  a pan-LDH antigen to  
provide a semiquantitative estimate of parasite density, are 
not generalizable to areas where other Plasmodium species are 
common.
Finally, we had a higher rate of study nonparticipation among 
younger children whose parents may have declined additional 
testing once the RDT results were known. However, we found 
little evidence in differences in clinical status between those who 
did and did not participate, partially mitigating this concern.
CONCLUSIONS
A dual-antigen RDT that detects HRP2 and pan-pLDH 
has high sensitivity for the detection of severe malaria in an 
area of high transmission and P. falciparum predominance, 
making it a promising tool in the triage of children with 
malaria in similar low-resource settings. The test was 
particularly sensitive among children aged <5 years. Notably, 
the RDT demonstrated signifi-cantly higher sensitivity for the 
detection of severe malaria than commonly used clinical 
criteria. Given the imperfect specificity of a dual-band positive 
assay, however, further work is needed 
to validate and operationalize diagnostic and treatment algo-
rithms so as not to overwhelm referral networks.
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